Reinvent Pharma is a patient-oriented company.

The company is developing therapeutics based on a combination of approved drugs designed to improve the clinical outcome of immune and targeted therapies.

The company's initial main field of interest is a selected niche of targeted solid tumors such as pancreatic, liver, bile duct, and brain tumors.